Johnson & Johnson 10Q 2015 Q1 Quarterly report | JNJ Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: antibody, Apotex, back, ban, begun, BENECOL, Biological, BPCIA, calendar, canagliflozin, Cardinal, Chicago, Clara, Clause, closest, Closure, coincide, composed, comprised, conclusion, consent, Constitution, contractual, Cook, Cosmetic, Costco, country, deficiency, denial, distributor, divested, electrophysiology, Employer, enforceable, expedient, fact, failure, fine, Food, forfeiture, Greek, guilty, harmed, horizontal, ichorcumab, implantation, Indictment, initiative, intended, intimate, ITC, JJDC, JJVCI, Langone, Life, Metabolism, milestone, misdemeanor, moot, nuisance, opioid, Orange, passed, Pharmatech, plea, PPC, premature, procedural, procurement, prospective, purportedly, reclassification, reinstated, reinstitute, reserve, retail, ROGAINE, Santa, simplify, Simplifying, spine, statute, streamline, substituted, sue, tapentadol, taxable, Tennessee, UC, unilateral, unnamed, unrealized, Utah, vertical, view, wedge, Wisconsin, world

Removed: Abbott, accelerated, Affordable, allege, argued, arterial, assert, assigned, Atlanta, aware, Benckiser, bidding, biliary, Bioresearch, Biotechnology, bortezomib, bound, brand, breach, calculated, capitalizing, Caribbean, Centocor, Central, CFC, challenge, China, clarifying, Code, Coleman, continuing, Controlled, controlling, CPI, created, decade, determination, developer, disclose, Distribution, domestic, Donovan, DORIBAX, DURALOC, duty, EDURANT, Elsker, enacted, ENDOPATH, equal, erroneously, exist, expressed, extent, favorably, feature, fiduciary, flexible, geographic, George, governance, Howmedica, implement, independent, Index, Infection, innovative, Inspector, insulin, interference, interlocutory, invention, investigated, IR, jurisdiction, Kft, launch, Le, leading, Leon, mechanism, mediation, medication, Medtronic, MiniMed, misleading, misrepresentation, Monk, Mother, negligent, newly, nominal, Norwich, objected, OCI, OMJ, Osmotic, Osmotica, overpayment, Par, parent, peripheral, Ping, powered, PR, prepared, pressure, Prevention, principle, prolonged, proxy, Puerto, qualifying, recently, Reckitt, recommended, recover, referenced, refiled, Regional, reject, remuneration, repatriation, resolved, responding, responsibly, retroactive, Rico, rilpivirine, risperidone, Ronald, Salfeld, scalpel, SDNY, secure, Shanghai, shareholder, shift, side, significantly, SIMPONI, sodium, Spamer, Stapler, Stenting, strategic, Stryker, supporting, Szolgaltato, taxing, Trident, Trust, unanimously, unenforceable, unfavorable, updated, VELCADE, voluntarily, withdrew

Johnson & Johnson (JNJ) 10-Q2015 Q1 Quarterly report

Content analysis